We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting Neglected Diseases

News   Aug 16, 2016

 
Targeting Neglected Diseases
 
 
 

RELATED ARTICLES

Single Low-dose of Intravenous Ketamine Relieves Depressive Symptoms With Mild Side Effects

News

National Institutes of Health researchers found that a single, low-dose ketamine infusion was relatively free of side effects for patients with treatment-resistant depression.

READ MORE

Cell Therapy Aims To Improve Memory and Prevent Seizures Following Traumatic Brain Injury

News

A team from the University of California, Irvine has developed a cell therapy to improve memory and prevent seizures in mice following traumatic brain injury.

READ MORE

Antibody Has the Ability To Halt Progression of Pulmonary Arterial Hypertension

News

Scientists have identified a novel antibody that has the potential to become a new treatment for pulmonary arterial hypertension (PAH). The antibody was found to stop the progress of the disease in rodent and cell models, and reverse the proliferation of cells which cause the arteries to thicken.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE